Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 187.54 million compared to CNY 202.99 million a year ago. Revenue was CNY 187.54 million compared to CNY 202.99 million a year ago.

Net income was CNY 30.1 million compared to CNY 29.35 million a year ago. Basic earnings per share from continuing operations was CNY 0.0721 compared to CNY 0.0732 a year ago. Diluted earnings per share from continuing operations was CNY 0.0721 compared to CNY 0.0732 a year ago.